Verbal Labels Can Triple Perceived Risk in Clinical Trials Dianne C. BerryMark Hochhauser Medical Communications 30 December 2006 Pages: 249 - 258
Electronic Diaries: Exploring Cross-Cultural Preferences and Acceptability Lucy AbrahamBelinda FieldJames S. Streeter Medical Communications 30 December 2006 Pages: 259 - 266
A Confidence Interval for the Maximal Mean QT Interval Change Caused by Drug Effect Morris L. EatonRobb J. MuirheadSheela Kolluri QT Interval Prolongation 30 December 2006 Pages: 267 - 271
Erratum to: Safer, Better, More Appropriate: Clinical Trial Design for Pediatric Drug Labels Susan K. McCuneLisa L. MathisW. Rodriguez Erratum 30 December 2006 Pages: 272 - 272
Estimation of Proarrhythmic Hazards by QT Prolongation/Shortening: QT Obsession? Luc M. Hondeghem QT Interval Prolongation 30 December 2006 Pages: 273 - 279
Issues Facing Development of New Innovative Medicines Jean A. YagerRaymond Starrett Drug Development 30 December 2006 Pages: 281 - 289
Proposed Terminology Changes to Facilitate the Analysis of MedDRA®-Coded Data Anna C. Zhao-WongEva RumpPatrick Revelle Drug Development 30 December 2006 Pages: 291 - 303
The US Pharmacopeia during the 2000–2005 Cycle Roger L. Williams US Pharmacopeia 30 December 2006 Pages: 305 - 316
Standards-Setting Activities of the US Pharmacopeia during the 2000–2005 Cycle Roger L. Williams US Pharmacopeia 30 December 2006 Pages: 317 - 329
An Improved Process for the Creation, Maintenance, and Documentation of Analysis-ready Data Allan Glaser Statistics 30 December 2006 Pages: 331 - 335
Development of a Content Uniformity Test Suitable for Large Sample Sizes Dennis SandellKim VukovinskyJoep Timmermans Statistics 30 December 2006 Pages: 337 - 344
The WIZARD Trial as a Case Study of Flexible Clinical Trial Design Thomas D. CookRebecca J. BennerMarian R. Fisher Statistics 30 December 2006 Pages: 345 - 353
Joint DIA/HESI/SAPS Conference on Environmental Assessment of Human Medicines Abstract 30 December 2006 Pages: 355 - 364